Brian L. Winstead

Sarepta Therapeutics
Sr. Director Facilities, Engineering and EHS
Brian Winstead has over 25 years of experience in the pharmaceutical industry leading small and large scale GMP facility builds. His current role as program manager involves leadinga large build for CSL Behring’snew cardiovascular drug, currently in Phase III clinical trials,launch and supportofCSL’s gene therapy acquisition,integration efforts,and facility build in Pasadena,California. Prior to joining CSL, Brian held multiple leadership roles in project and program management with Novartis, Pfizer Global Engineering, King Pharmaceuticals Global Engineering and Wyeth. In these roles,he led capital project programs ranging from $1Mto $200MM encompassing GMP facility builds for new drug launches, technologies in aseptic processing, oral solid dose, and gene cell therapy. Brian’s education includes a BS in Mechanical Engineering from North Carolina State University and Project Management Professional Certification. He is an active member in healthcare organizations including the Project Management Institute, International Society of Pharmaceutical Engineers, American Society of Mechanical Engineers and others.